$30 Billion Worldwide Immunoprotein Diagnostic Testing Industry to 2027 - Impact of COVID-19 on the Market
September 25, 2020 08:09 ET
|
Research and Markets
Dublin, Sept. 25, 2020 (GLOBE NEWSWIRE) -- The "Immunoprotein Diagnostic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The...
Insights on the High-density Multiplexed Diagnostic Assays Global Market to 2027 - Featuring Abbott Laboratories, Agilent Technologies & Hologic Among Others
September 24, 2020 07:59 ET
|
Research and Markets
Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "High-density Multiplexed Diagnostic Assays - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. ...
Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates
June 24, 2020 17:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
Aegea Biotechnologies, Inc. Announces the Issuance of 7 Additional Key U.S. Patents Relating to its Core, Next Generation Nucleic Acid Clinical Diagnostic Technologies and COVID-19 Test Development
May 18, 2020 08:13 ET
|
Tauriga Sciences
NEW YORK, NY and SAN DIEGO, CA, May 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Aegea Biotechnologies, Inc. ( “Aegea”) ( www.aegeabiotech.com), a biotechnology company focusing on the...